PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:34 AM ET

Sponsor Check › Person

DG
No photo found yet (own website and image search run after this page is viewed)

Daniel Geffken

Named as an officer, director or promoter on SEC Form D filings · PA · Dec 19, 2019 → Dec 19, 2019

1deal (issuers)
$26.4Mreported sold
17investors
1Form D filing
2019year on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:45 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Daniel Geffken is listed as a director on 1 SEC Form D filing by 1 issuer in Dec 2019: WINDTREE THERAPEUTICS INC /DE/ (Warrington, PA — biotechnology — 2019; $26.4M reported sold to 17 investors).

What this means One deal on file with the SEC, filed Dec 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Brian Schreiber (1 shared filing), Bruce Peacock (1 shared filing), Craig E. Fraser (1 shared filing), James Huang (1 shared filing), John R. Leone (1 shared filing) and 4 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 1 public filing for Daniel Geffken and found 6 differences, 1 worth asking the sponsor about: Paid seller listed without a CRD number: Rui Jin (HK) Consulting Management Company Limited; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Daniel Geffken has not run yet — it is joining a line of 24,221 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:45 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Daniel Geffken..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:45 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

6 differences found between the filings for Daniel Geffken — 1 worth asking about (compared 1 filing on Oct 24, 2026)

Worth asking · Dec 19, 2019

Paid seller listed without a CRD number: Rui Jin (HK) Consulting Management Company Limited — WINDTREE THERAPEUTICS INC /DE/

Rui Jin (HK) Consulting Management Company Limited is listed as receiving sales compensation on 1 filing (Dec 19, 2019) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Note · Jan 4, 2018 – Apr 4, 2023

Same name, different state: "Daniel Geffken" (CA) is a separate record

This page covers filings where the address state is PA. A separate record, "Daniel Geffken" with address state CA, is listed on 3 filings — most recently by CalciMedica, Inc. (Apr 4, 2023). Both records have filings in the same period (Dec 19, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jul 22, 2014 – Nov 2, 2022

Same name, different state: "Daniel Geffken" (MA) is a separate record

This page covers filings where the address state is PA. A separate record, "Daniel Geffken" with address state MA, is listed on 18 filings — most recently by Elicio Therapeutics, Inc. (Nov 2, 2022). Both records have filings in the same period (Dec 19, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · May 3, 2018 – Mar 30, 2021

Same name, different state: "Daniel E. Geffken" (A6) is a separate record

This page covers filings where the address state is PA. A separate record, "Daniel E. Geffken" with address state A6, is listed on 7 filings — most recently by ProMIS Neurosciences Inc. (Oct 21, 2022). Both records have filings in the same period (Dec 19, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jan 6, 2016 – Aug 17, 2017

Same name, different state: "Daniel Geffken" (KY) is a separate record

This page covers filings where the address state is PA. A separate record, "Daniel Geffken" with address state KY, is listed on 3 filings — most recently by Apellis Pharmaceuticals, Inc. (Aug 17, 2017). The two records do not overlap in time: this page has one filing dated Dec 19, 2019; the other runs Jan 6, 2016 to Aug 17, 2017.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Feb 11, 2014

Same name, different state: "Daniel E. Geffken" (ME) is a separate record

This page covers filings where the address state is PA. A separate record, "Daniel E. Geffken" with address state ME, is listed on 1 filing — most recently by Novira Therapeutics, Inc. (Feb 11, 2014). The two records do not overlap in time: this page has one filing dated Dec 19, 2019; the other has one filing dated Feb 11, 2014.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 1 offering reports sales commissions totalling $324,000; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Dec 19, 2019 D
WINDTREE THERAPEUTICS INC /DE/
File 021-356011
$324,000 (est.)$0$0Rui Jin (HK) Consulting Management Company Limited no CRD number reportedEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Daniel Geffken on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

WINDTREE THERAPEUTICS INC /DE/

Warrington, PA · Dec 19, 2019
  • Dec 19, 2019 · D · $26,424,996 sold of $26,424,996 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $26.4M from 17 investors (100% of the $26.4M target) as of the latest filing. Daniel is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (6)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Daniel Geffken — MA, 4 issuers, Jul 22, 2014 → Nov 2, 2022 · no shared issuer
  • Daniel Geffken — CA, 3 issuers, Jan 4, 2018 → Apr 4, 2023 · no shared issuer
  • Daniel E. Geffken — ME, 1 issuer, Feb 11, 2014 → Feb 11, 2014 · no shared issuer
  • Daniel Geffken — KY, 1 issuer, Jan 6, 2016 → Aug 17, 2017 · no shared issuer
  • Daniel E. Geffken — Ontario, Canada (as filed: A6), 1 issuer, May 3, 2018 → Mar 30, 2021 · no shared issuer
  • Daniel Geffken — NY, 1 issuer, Oct 11, 2018 → Oct 11, 2018 · no shared issuer

People around Daniel 9

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James Huang

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

John Tattory

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph M. Mahady

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

MT
No photo found yet (own website and image search run after this page is viewed)
Person

Mary B. Templeton

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

John R. Leone

Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Craig E. Fraser

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Steven A. Simonson

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Schreiber

Director · 1 shared filing (1 issuer)

Listed on the same filings as Daniel Geffken. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Peacock

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Bruce Peacock is on 6 issuers in total — a repeat sponsor. Their page lists every one.

Registrations and other filings

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Daniel Geffken by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Daniel Geffken is listed on: none on file. No website or social profile named in WINDTREE THERAPEUTICS INC /DE/'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #223,213 of 374,652 in line (1,207 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Warrington, PA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Daniel Geffken appears on a new Form D, or when a court case or SEC action is matched to them. See plans →